NASDAQ:VKTX

Viking Therapeutics Stock Predictions

etoro logo Buy VKTX
*Your capital is at risk
$29.33
+0.0400 (+0.137%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Oct 23, 2017 $3.02 +7.86% $2.80 X 92.10% 0
Oct 23, 2017 $3.00 +7.14% $2.80 X 92.90% 0
Oct 23, 2017 $5.00 +78.57% $2.80 X 21.40% 0
JS JS Pro
Oct 19, 2017 $2.54 -14.77% $2.98 X 85.20% 0
Oct 19, 2017 $2.80 -6.04% $2.98 X 94.00% 0
Aug 31, 2017 $1.09 +4.81% $1.04 X 95.20% 0
Aug 30, 2017 $1.08 -0.92% $1.09 X 99.10% 1
Aug 25, 2017 $1.05 -4.55% $1.10 X 95.50% 0
paoooolo paoooolo @paoooolo.2570
Jan 30, 2017 $1.50 +8.70% $1.38 X 91.30% 0
JS JS Pro
Oct 13, 2016 $1.20 +3.45% $1.16 X 96.60% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIKING THERAPEUTICS
Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE